HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
Develop a toolkit to set standards and support accelerated research, development, and introduction of priority paediatric formulations.
GAP-f
WHO and Unitaid in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group launched Toolkit for research and development of paediatric antiretroviral drugs and formulations available as PDF at http://www.who.int/hiv/pub/research-dev-toolkit-paediatric-arv-drug-formulation/en/ is also available as online tool at https://globalhealthtrainingcentre.tghn.org/research-toolkit-paediatric-antiretroviral-drug-and-formulation-development/ . Following wide dissemination at AIDS 2018 and the Paediatric Workshop the toolkit is being further disseminated to industry and relevant stakeholder via a series of 6 webinars that will be completed by the end of the year (2 webinars already convened). Scientific papers for further dissemination are under development.
-
Toolkit developed and launched at IAC.
-
-
-
-
-
-
-